Search Within

Jazmin Schwartz

Formats
  1. Journal Article (20)
  2. Meeting Abstract (20)
  3. Review (1)
Groups
  1. Medical Physics (41)
  2. Radiology, Department of (36)
  3. Molecular Imaging and Therapy Service (32)
  4. Sloan Kettering Institute Postdocs (19)
  5. Radiochemistry and Imaging Sciences Service (13)
  6. GSK Faculty (9)

More Groups

People
  1. John Humm (24)
  2. Heiko Schoder (14)
  3. Milan Grkovski (12)
  4. Pat Zanzonico (12)
  5. Neeta Pandit-Taskar (9)
  6. Sadek Nehmeh (9)

More People

Years
  1. 2025 (2)
  2. 2024 (1)
  3. 2023 (10)
  4. 2022 (5)
  5. 2020 (2)
  6. 2019 (1)

More Years

Publications
  1. Journal of Nuclear Medicine (22)
  2. Medical Physics (5)
  3. Clinical Imaging (2)
  4. Journal of Clinical Oncology (2)
  5. Journal of Vascular and Interventional Radiology (2)
  6. Cancer (1)

More Publications

Publishers
  1. Society of Nuclear Medicine (22)
  2. American Association of Physicists in Medicine (5)
  3. Elsevier Inc. (3)
  4. Springer (3)
  5. American Society of Clinical Oncology (2)
  6. Elsevier Science, Inc. (2)

More Publishers

Results (41)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Computational nuclear oncology toward precision radiopharmaceutical therapies: Ethical, regulatory, and socioeconomic dimensions of theranostic digital twins
    Journal Article

    Strigari, L.; Schwarz, J.; Bradshaw, T.; Brosch-Lenz, J.; Currie, G.; El-Fakhri, G.; Jha, A. K.; Mežinska, S.; Pandit-Taskar, N.; Roncali, E.; more...
    Journal of Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • Computational nuclear oncology toward precision radiopharmaceutical therapies: Current tools, techniques, and uncharted territories
    Review

    Yusufaly, T.; Roncali, E.; Brosch-Lenz, J.; Uribe, C.; Jha, A. K.; Currie, G.; Dutta, J.; El-Fakhri, G.; McMeekin, H.; Pandit-Taskar, N.; more...
    Journal of Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • Computational nuclear oncology for precision radiopharmaceutical therapies
    Meeting Abstract

    Yusufaly, T.; Roncali, E.; Uribe, C.; Shi, K. Y.; Bradshaw, T.; Jha, A.; Strigari, L.; Currie, G.; McMeekin, H.; Schwartz, J.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Streamlining personalized dosimetry for I131-apamistamab using a Co-57 sheet source to circumvent the need for radionuclide-specific attenuation correction
    Meeting Abstract

    Schwartz, J.; Brodin, P.; Spross, J.; Haeuber, E.; Fisher, D.; Pandit-Taskar, N.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Multi-parametric imaging of glioblastoma using pseudo-simultaneous [18F]-FMISO/[18F]-FLT PET
    Meeting Abstract

    Nehmeh, S.; Magge, R.; Schwartz, T.; Fine, H.; Liechty, B.; Kadrmas, D.; Schwartz, J.; Schuck, P.; Ivanidze, J.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • 18F-MFBG PET imaging in patients with neuroblastoma: Lesion targeting and comparison with MIBG
    Meeting Abstract

    Pandit-Taskar, N.; Mauguen, A.; Basu, E.; Price, A.; Behr, G.; Min, R.; Lyashchenko, S.; Schwartz, J.; Modak, S.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Machine learning applications to optimize dosimetric imaging of I131-apamistamab for bone marrow conditioning in relapsed/refractory acute myeloid leukemia (R/R AML)
    Meeting Abstract

    Brodin, P.; Schwartz, J.; Wang, W.; Spross, J.; Pandit-Taskar, N.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • TITLE: A pilot study of 89Zr-DFO-REGN3767 anti-LAG-3 antibody positron emission tomography in patients with diffuse large B-cell lymphoma
    Meeting Abstract

    Pandit-Taskar, N.; Shutian, R.; Grkovski, M.; Schwartz, J.; Lyashchenko, S.; Cheung, K.; Uldrick, T.; Ma, D.; Giurleo, J.; Palomba, L.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Index lesion dosimetry for (177)Lu-PSMA-617 radiopharmaceutical therapy combined with stereotactic body radiotherapy in patients with oligometastatic castration-sensitive prostate cancer
    Meeting Abstract

    Grkovski, M.; O'Donoghue, J.; Imber, B.; Andl, G.; Tu, C.; Lafontaine, D.; Schwartz, J.; Thor, M.; Zelefsky, M.; Humm, J.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Lesion dosimetry for [(177)Lu]Lu-PSMA-617 radiopharmaceutical therapy combined with stereotactic body radiotherapy in patients with oligometastatic castration-sensitive prostate cancer
    Journal Article

    Grkovski, M.; O'Donoghue, J. A.; Imber, B. S.; Andl, G.; Tu, C.; Lafontaine, D.; Schwartz, J.; Thor, M.; Zelefsky, M. J.; Humm, J. L.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save